Please use this identifier to cite or link to this item:
https://doi.org/10.3390/cancers12123777
DC Field | Value | |
---|---|---|
dc.title | Correction to: Sundararajan, v., et al. snai1-driven sequential emt changes attributed by selective chromatin enrichment of rad21 and grhl2. cancers 2020, 12, 1140 | |
dc.contributor.author | Sundararajan, V. | |
dc.contributor.author | Tan, M. | |
dc.contributor.author | Tan, T.Z. | |
dc.contributor.author | Pang, Q.Y. | |
dc.contributor.author | Ye, J. | |
dc.contributor.author | Chung, V.Y. | |
dc.contributor.author | Huang, R.Y.-J. | |
dc.date.accessioned | 2021-08-10T03:11:20Z | |
dc.date.available | 2021-08-10T03:11:20Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Sundararajan, V., Tan, M., Tan, T.Z., Pang, Q.Y., Ye, J., Chung, V.Y., Huang, R.Y.-J. (2020). Correction to: Sundararajan, v., et al. snai1-driven sequential emt changes attributed by selective chromatin enrichment of rad21 and grhl2. cancers 2020, 12, 1140. Cancers 12 (12) : 1-2. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers12123777 | |
dc.identifier.issn | 2072-6694 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/196311 | |
dc.description.abstract | The authors wish to make the following corrections to this paper [1]: Section 2.1, paragraph 2, line 12, (Figure 1G) should be (Figure 1F,G); (Figure 1H) should be (Figure 1F,H). Section 2.2, paragraph 2, first sentence: “Our results show that the expression of ERBB3 was significantly downregulated in SNAI1-OVCA420 cells at the mRNA and protein levels” should be “Our results show that the expression of ERBB3 was significantly downregulated in SNAI1-OVCA420 cells at the mRNA and protein levels (Figure 2B,D)”. Section 2.2, paragraph 2, line 3, (Figure 3B,D) should be (Figure 2B,D); line 5, (Figure 3C,D) should be (Figure 2C,D); line 7, (Figure 3E,F) should be (Figure 2E,F). Section 2.3, paragraph 1, line 21, (Figure 3D) should be (Figure 2D). Section 2.4, paragraph 1, “we tested whether GRHL2 would play a role in altering the RAD21-mediated enrichment along the PERP and ERBB3 loci in our EMT spectrum model” should be “we tested whether GRHL2 would play a role in altering the RAD21-mediated enrichment along the PERP and ERBB3 loci in our EMT spectrum model (Figure 4A)”. Section 2.4, paragraph 1, last sentence: “with a modest reduction of PERP levels (Figure 4A).” should be “with a modest reduction of PERP levels (Figure 4B,D)”. Section 2.4, paragraph 2, first sentence: “a modest increase PERP transcript levels (Figure 4A)” should be “a modest increase PERP transcript levels (Figure 4C)”. Section 2.4, paragraph 2, third sentence: “the intron1 (P12) regions in GRHL2 knockdown cells (Figure 4B, left)” should be “the intron1 (P12) regions in GRHL2 knockdown cells (Figure 4E, left)”. Section 2.4, paragraph 2, fourth sentence: “the intron1 (E20) amplicon regions along the ERBB3 loci (Figure 4B, right)” should be “the intron1 (E20) amplicon regions along the ERBB3 loci (Figure 4E, right)”. Section 2.4, paragraph 2, fifth sentence: “the 3? UTR/poly-A-tail (P18) amplicon regions along the PERP loci (Figure 4C, left)” should be “the 3? UTR/poly-A-tail (P18) amplicon regions along the PERP loci (Figure 4F, left)”; “the intron1 (E19 and 20) amplicon regions along the ERBB3 loci (Figure 4C, right)” should be “the intron1 (E19 and 20) amplicon regions along the ERBB3 loci (Figure 4F, right)”. Section 3, paragraph 1, last sentence, “whereas expressions of TWIST1 and ZEB1/2 are higher in cell-line IM and M phenotypes” should be “whereas expressions of TWIST1 and ZEB1/2 are higher in cell-line IM and M phenotypes [8]”. The authors would like to apologize for any inconvenience caused to the readers by these changes. Conflicts of Interest: The authors declare no conflict of interest. Reference 1. Sundararajan, V.; Tan, M.; Zea Tan, T.; Pang, Q.Y.; Ye, J.; Chung, V.Y.; Huang, R.Y.-J. SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2. Cancers 2020, 12, 1140. [CrossRef] [PubMed]. © 2020 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.publisher | MDPI AG | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2020 | |
dc.type | Others | |
dc.contributor.department | CANCER SCIENCE INSTITUTE OF SINGAPORE | |
dc.contributor.department | OBSTETRICS & GYNAECOLOGY | |
dc.description.doi | 10.3390/cancers12123777 | |
dc.description.sourcetitle | Cancers | |
dc.description.volume | 12 | |
dc.description.issue | 12 | |
dc.description.page | 1-2 | |
dc.type.subtype | Erratum | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3390_cancers12123777.pdf | 160.67 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License